Insights into the HER-2 receptor tyrosine kinase mechanism and substrate specificity using a transient kinetic analysis

被引:30
作者
Jan, AY
Johnson, EF
Diamonti, AJ
Carraway, KL
Anderson, KS
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[2] Beth Israel Deaconess Med Ctr, Harvard Inst Med, Div Signal Transduct, Boston, MA 02215 USA
关键词
D O I
10.1021/bi9924922
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HER-2/erbB-2/c-neu proto-oncogene encodes for an EGF receptor-like protein which has been implicated in the pathogenesis of several human malignancies. Although much has been learned about the physiological significance of this receptor tyrosine kinase, its catalytic mechanism remains poorly understood. We have expressed, purified, and characterized two recombinant proteins corresponding to a full-length (HCD) and truncated (HKD) construct of the HER-2 intracellular tyrosine kinase domain and have identified an optimal substrate (GGMEDIYFEFMGGKKK; HER2Peptide) through screening of a degenerate peptide library. We have conducted a transient kinetic analysis of the HER-2 proteins (HCD and HKD) to illuminate mechanistic details of the HER-2 pathway. In particular, stopped-flow fluorescence studies with mant (N-methylanthraniloyl)-nucleotide derivatives provided direct measurements of the association and dissociation rate constants for these nucleotide interactions with the HER-2 recombinant proteins, thereby enabling the determination of nucleotide k(d) values. Moreover, the actual step of chemical catalysis was isolated using rapid chemical quench techniques and shown to occur approximately 3-fold faster than the steady-state rate which corresponds to product release. Evidence is also provided that suggests a conformational change that is partially rate-limiting at least in HCD. Furthermore, the role that the phosphorylation state of the protein may play on catalysis was examined. Studies carried out with pn-phosphorylated recombinant HER-2 proteins suggest that while autophosphorylation is not a prerequisite for enzymatic activity, this protein modification actually directly affects the catalytic mechanism by enhancing the rate of ADP release and that of the rate-limiting step. While a pre-steady-state kinetic analysis has been carried out on the catalytic subunit of cAMP-dependent serine/threonine kinase, to our knowledge, this study represents the first reported transient kinetic investigation of a receptor tyrosine kinase. This work serves as a basis for comparison of these two important protein kinase families and in this report we highlight these similarities and differences.
引用
收藏
页码:9786 / 9803
页数:18
相关论文
共 73 条
[1]   THE TRANSFORMING POTENTIAL OF THE C-ERBB-2 PROTEIN IS REGULATED BY ITS AUTOPHOSPHORYLATION AT THE CARBOXYL-TERMINAL DOMAIN [J].
AKIYAMA, T ;
MATSUDA, S ;
NAMBA, Y ;
SAITO, T ;
TOYOSHIMA, K ;
YAMAMOTO, T .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (02) :833-842
[2]   KINETIC AND STRUCTURAL-ANALYSIS OF ENZYME INTERMEDIATES - LESSONS FROM EPSP SYNTHASE [J].
ANDERSON, KS ;
JOHNSON, KA .
CHEMICAL REVIEWS, 1990, 90 (07) :1131-1149
[3]   THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
NATURE, 1986, 319 (6050) :226-230
[4]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[5]   ANALYSIS OF NUMERICAL-METHODS FOR COMPUTER-SIMULATION OF KINETIC PROCESSES - DEVELOPMENT OF KINSIM - A FLEXIBLE, PORTABLE SYSTEM [J].
BARSHOP, BA ;
WRENN, RF ;
FRIEDEN, C .
ANALYTICAL BIOCHEMISTRY, 1983, 130 (01) :134-145
[6]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[7]  
BERTICS PJ, 1985, J BIOL CHEM, V260, P4642
[8]  
BERTICS PJ, 1988, J BIOL CHEM, V263, P3610
[9]  
CADENA DL, 1994, J BIOL CHEM, V269, P260
[10]  
CARPENTER G, 1979, J BIOL CHEM, V254, P4884